It can be isolated from Vitis coignetiae or from Gnetum cleistostachyum.

[1] It shows an action on prostate cancer cells.

[2] It has been shown to inhibit the human cytochrome P450 1A1,[3] an enzyme implicated in the biotransformation of a number of carcinogenic and immunotoxic compounds.

Injected in rats, rhapontigenin shows a rapid glucuronidation and a poor bioavailability.

This article about an aromatic compound is a stub.